Oxford Cancer Biomarkers

📍 Oxford, United Kingdom🗓 Founded 2012👥 6 employees💰 Last funded Mar 2023
Biotechnology Research🌐 oxfordcancerbiomarkers.com
Website LinkedIn
Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV, Ningbo My-BioMed Biotechnology Co.,Ltd., CancerRop Co. Ltd., and the University of Oxford. Oxford Cancer Biomarkers range of predictive biomarkers will help clinicians deliver personalised care to patients with colorectal cancer. The first to be launched is ToxNav, a 20 SNP germline assay that predicts individuals’ propensity to develop life-threatening adverse reactions from 5FU/capecitabine chemotherapy. OncoProg; a digital pathology test for the recurrence of Stage II tumours is already available in China. The company is working with academic partners to develop a population-based genome test for the lifetime risk of developing colorectal cancer.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Oxford Cancer Biomarkers?
Oxford Cancer Biomarkers has 2 investors on record on gritt.io, including 1 early-stage backers.
When did Oxford Cancer Biomarkers last raise funding?
The most recent investment in Oxford Cancer Biomarkers recorded on gritt.io was in March 2023.
When was Oxford Cancer Biomarkers founded?
Oxford Cancer Biomarkers was founded in 2012.
What industry is Oxford Cancer Biomarkers in?
Oxford Cancer Biomarkers operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oxford Cancer Biomarkers based?
Oxford Cancer Biomarkers is headquartered in Oxford, United Kingdom.